250 related articles for article (PubMed ID: 19591597)
1. Risk of developing specific AIDS-defining illnesses in patients coinfected with HIV and hepatitis C virus with or without liver cirrhosis.
d'Arminio Monforte A; Cozzi-Lepri A; Castagna A; Antinori A; De Luca A; Mussini C; Caputo SL; Arlotti M; Magnani G; Pellizzer G; Maggiolo F; Puoti M;
Clin Infect Dis; 2009 Aug; 49(4):612-22. PubMed ID: 19591597
[TBL] [Abstract][Full Text] [Related]
2. Persistently low CD4 cell counts are associated with hepatic events in HCV/HIV coinfected patients: data from the national free antiretroviral treatment program of China.
Lin W; Zhong H; Wen C; He Y; Zheng X; Li H; Chen X; He H; Chen J; Chen L; Liu C; Tang X; Cai W; Li L
Chin Med J (Engl); 2022 Nov; 135(22):2699-2705. PubMed ID: 36574222
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and risk factors for patient-reported joint pain among patients with HIV/hepatitis C coinfection, hepatitis C monoinfection, and HIV monoinfection.
Ogdie A; Pang WG; Forde KA; Samir BD; Mulugeta L; Chang KM; Kaplan DE; Amorosa VK; Kostman JR; Reddy RK; Schumacher RH; Lo Re V
BMC Musculoskelet Disord; 2015 Apr; 16():93. PubMed ID: 25896674
[TBL] [Abstract][Full Text] [Related]
4. Statin drugs decrease progression to cirrhosis in HIV/hepatitis C virus coinfected individuals.
Oliver NT; Hartman CM; Kramer JR; Chiao EY
AIDS; 2016 Oct; 30(16):2469-2476. PubMed ID: 27753678
[TBL] [Abstract][Full Text] [Related]
5. Risk of liver decompensation with cumulative use of mitochondrial toxic nucleoside analogues in HIV/hepatitis C virus coinfection.
Lo Re V; Zeldow B; Kallan MJ; Tate JP; Carbonari DM; Hennessy S; Kostman JR; Lim JK; Goetz MB; Gross R; Justice AC; Roy JA
Pharmacoepidemiol Drug Saf; 2017 Oct; 26(10):1172-1181. PubMed ID: 28722244
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis C virus and human immunodeficiency virus coinfection among attendants of voluntary counseling and testing centre and HIV follow up clinics in Mekelle Hospital.
Hadush H; Gebre-Selassie S; Mihret A
Pan Afr Med J; 2013; 14():107. PubMed ID: 23717721
[TBL] [Abstract][Full Text] [Related]
7. Impact of hepatitis coinfection on healthcare utilization among persons living with HIV.
Crowell TA; Berry SA; Fleishman JA; LaRue RW; Korthuis PT; Nijhawan AE; Moore RD; Gebo KA;
J Acquir Immune Defic Syndr; 2015 Apr; 68(4):425-31. PubMed ID: 25559601
[TBL] [Abstract][Full Text] [Related]
8. Increased risk of non-AIDS-defining cancers in Asian HIV-infected patients: a long-term cohort study.
Nagata N; Nishijima T; Niikura R; Yokoyama T; Matsushita Y; Watanabe K; Teruya K; Kikuchi Y; Akiyama J; Yanase M; Uemura N; Oka S; Gatanaga H
BMC Cancer; 2018 Nov; 18(1):1066. PubMed ID: 30400779
[TBL] [Abstract][Full Text] [Related]
9. Prevalence, incidence, and outcomes of hepatitis E virus coinfection in patients with chronic hepatitis C.
Jang ES; Choi GH; Kim YS; Kim IH; Lee YJ; Cho SB; Kim YT; Jeong SH
Sci Rep; 2023 Aug; 13(1):13632. PubMed ID: 37604848
[TBL] [Abstract][Full Text] [Related]
10. Factors associated with high alanine aminotransferase (ALT) and cirrhosis in people living with HIV on combination antiretroviral treatment (cART) in the Asia-Pacific.
Rupasinghe D; Choi JY; Yunihastuti E; Kiertiburanakul S; Ross J; Ly PS; Chaiwarith R; Do CD; Chan YJ; Kumarasamy N; Avihingsanon A; Kamarulzaman A; Khusuwan S; Zhang F; Lee MP; Van Nguyen K; Merati TP; Sangle S; Oon Tek N; Tanuma J; Ditangco R; Sim BLH; Pujari S; Jiamsakul A;
J Med Virol; 2022 Nov; 94(11):5451-5464. PubMed ID: 35869413
[TBL] [Abstract][Full Text] [Related]
11. Nationwide surveillance of AIDS-defining illnesses among HIV patients in Japan from 1995 to 2017.
Tanaka T; Oshima K; Kawano K; Tashiro M; Tanaka A; Fujita A; Tsukamoto M; Yasuoka A; Teruya K; Izumikawa K
PLoS One; 2021; 16(8):e0256452. PubMed ID: 34411193
[TBL] [Abstract][Full Text] [Related]
12. Long-term follow-up for incident cirrhosis among pediatric cancer survivors with hepatitis C virus infection.
Stallings-Smith S; Krull KR; Brinkman TM; Hudson MM; Ojha RP
J Clin Virol; 2015 Oct; 71():18-21. PubMed ID: 26370309
[TBL] [Abstract][Full Text] [Related]
13. Differential Effects of AIDS and Chronic Human Immunodeficiency Virus Infection on Gray Matter Volume.
O'Connor EE; Zeffiro TA; Lopez OL; Becker JT
Clin Infect Dis; 2021 Oct; 73(7):e2303-e2310. PubMed ID: 33053187
[TBL] [Abstract][Full Text] [Related]
14. Trends in Hepatitis C Virus and HIV Care Outcomes Among People With HIV in Georgia, United States, 2014-2019.
Evans KN; Wortley PM; Gandhi A; Bradley H
Public Health Rep; 2023 Nov; ():333549231205341. PubMed ID: 37924243
[TBL] [Abstract][Full Text] [Related]
15. Computational study of a co-infection model of HIV/AIDS and hepatitis C virus models.
Dayan F; Ahmed N; Bariq A; Akgül A; Jawaz M; Rafiq M; Raza A
Sci Rep; 2023 Dec; 13(1):21938. PubMed ID: 38081841
[TBL] [Abstract][Full Text] [Related]
16. Hepatotoxicity during legacy cancer chemotherapy in patients infected with hepatitis C virus: A retrospective cohort study.
Szpakowski JL; Tucker LY; Baer DM; Pauly MP
Can Liver J; 2022; 5(1):43-60. PubMed ID: 35990784
[TBL] [Abstract][Full Text] [Related]
17. Pathogenesis, clinical course, and recent issues in HIV-1-infected Japanese hemophiliacs: a three-decade follow-up.
Oka S; Ikeda K; Takano M; Ogane M; Tanuma J; Tsukada K; Gatanaga H
Glob Health Med; 2020 Feb; 2(1):9-17. PubMed ID: 33330768
[TBL] [Abstract][Full Text] [Related]
18. The Correlation between Anthropometric Variables and Muscular Strength in Patients Coinfected with Leprosy and HIV.
Novais DVDC; do Nascimento MGB; Lopes GL; de Brito JAGSM; Carneiro TX; Souza GS; Xavier MB
Indian J Dermatol; 2023; 68(2):127-134. PubMed ID: 37275828
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
